HVTN 505 vaccine induced antibodies nonspecific for HIV
Thursday, July 30, 2015 - 19:00
in Health & Medicine
A new study helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection despite robustly inducing anti-HIV antibodies: the vaccine stimulated antibodies that recognized HIV as well as microbes commonly found in the intestinal tract, part of the body's microbiome.